☆ 4.6 Article

Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status

PLOS ONE (2023)

Related references

Note: Only part of the references are listed.

Article Multidisciplinary Sciences

Severe and mild-moderate SARS-CoV-2 vaccinated patients show different frequencies of IFNγ-releasing cells: An exploratory study

Eugenio Garofalo et al.

Summary: In this study, we evaluated the spike-specific immune response in patients with breakthrough SARS-CoV-2 infection after receiving two doses of the BNT162b2 mRNA vaccine. The results showed that severe COVID-19 patients requiring hospitalization had lower levels of spike-specific IFN gamma-releasing cells compared to mild-moderate patients and healthy subjects, despite similar antibody titers.

PLOS ONE (2023)

Add to Collection

Article Multidisciplinary Sciences

Signature of long-lived memory CD8+ T cells in acute SARS-CoV-2 infection

Sarah Adamo et al.

Summary: Researchers used spectral flow cytometry combined with cellular indexing of transcriptomes and T cell receptor sequencing to longitudinally characterize individual SARS-CoV-2-specific CD8(+) T cells from patients with COVID-19, identifying a distinct signature marking long-lived memory CD8(+) T cells. The study found that SARS-CoV-2-specific memory CD8(+) T cells persisting 1 year after acute infection express specific markers and exhibit characteristics resembling effector memory T cells, and that certain transcriptional signatures and signaling pathways are associated with the fate of individual clones of these cells.

NATURE (2022)

Add to Collection

Article Immunology

CD4+T Cell Immune Specificity Changes After Vaccination in Healthy And COVID-19 Convalescent Subjects

Laura Esparcia-Pinedo et al.

Summary: The immune response to the SARS-CoV-2 vaccination is important for developing new vaccines and optimizing prevention strategies. Analysis of the adaptive immunity in healthy donors and convalescent individuals before and after vaccination revealed specific changes in CD4+ T cell reactivity and antibody levels.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Immunology

Immunotherapy of COVID-19: Inside and Beyond IL-6 Signalling

Gaetano Zizzo et al.

Summary: IL-6 inhibitors have shown significant efficacy in treating COVID-19 patients, particularly in severe cases. Identifying baseline characteristics of patients and determining the optimal window for treatment based on specific biomarkers are crucial for successful outcomes in disease management.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients

Antti Hurme et al.

Summary: Despite the emergence of novel variants of SARS-CoV-2, vaccines can still provide protection against Alpha, Beta, Gamma, and Delta variants for at least 6 months.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection

Arbor G. Dykema et al.

Summary: The study analyzed the CD4+ T cell receptor repertoire specific to the SARS-CoV-2 spike glycoprotein before and after vaccination in COVID-19 convalescent patients and healthy donor vaccine recipients. The post-vaccine repertoire mainly consisted of vaccine-induced clones, which were distinct from the repertoire induced by natural infection.

EBIOMEDICINE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 Donors

Alison Tarke et al.

Summary: This study assessed SARS-CoV-2-specific CD4+ and CD8+ T cell responses in acute COVID-19 patients and found that early S-specific CD4+ T cell responses were correlated with milder disease outcomes, especially within the first two weeks of symptom onset. Patients with milder disease had stronger CD4+ T cell responses that recognized non-S proteins in addition to S, while severe COVID-19 patients showed lower magnitudes of CD4+ T cell responses and a narrower repertoire.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Multidisciplinary Sciences

Detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests

Masashi Nishimura et al.

Summary: Silent infection is estimated to be 6.0% overall and 21.1% among healthcare workers in the COVID-19 ward. Periodical screening with IgG (RBD) in addition to PCR can effectively detect ongoing infection, while IgG (N)(0.2) may be the most reliable indicator for the surveillance of morbidity in the population.

PLOS ONE (2022)

Add to Collection

Article Medical Laboratory Technology

CD69 flow cytometry to complement interferon-γ release assay for active tuberculosis

Yoonjung Kim et al.

Summary: In this study, a novel assay using CD69 flow cytometry (FC) was developed to complement the interferon-gamma (IFN-gamma) release assay (IGRA) for diagnosing tuberculosis (TB). The results showed that CD69 FC could clarify indeterminate IGRA results and identify active TB.

CYTOMETRY PART B-CLINICAL CYTOMETRY (2022)

Add to Collection

Review Immunology

SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic

Antonio Bertoletti et al.

Summary: This review summarizes the evidence supporting the role of SARS-CoV-2-specific T cells in disease protection and analyzes the different factors that may influence the magnitude, function, and anatomical localization of these T cells, as well as their impact on protecting the host from severe COVID-19 development.

IMMUNITY (2022)

Add to Collection

Article Infectious Diseases

Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4+ and CD8+ T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay

Alessandra Aiello et al.

Summary: This study characterized the SARS-CoV-2-specific T cell response using the QuantiFERON SARS-CoV-2 assay compared with a homemade interferon (IFN)-gamma release assay (IGRA). The results showed that the QuantiFERON assay detected T cell responses mediated by both CD4(+) and CD8(+) T cells, while the homemade IGRA-SPIKE test had a higher response rate.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Review Cell Biology

Count on us: T cells in SARS-CoV-2 infection and vaccination

Katherine Kedzierska et al.

Summary: This article discusses epitope-specific CD8(+) and CD4(+) T cell responses to SARS-CoV-2 infection and vaccination, their persistence in long-term memory, and their role in limiting disease severity.

CELL REPORTS MEDICINE (2022)

Add to Collection

Article Immunology

Conversion of effector CD4+ T cells to a CD8+ MHC II-recognizing lineage

Elizabeth Robins et al.

Summary: Recent research has revealed that CD4(+) and CD8(+) T cells in adaptive immunity can exhibit significant lineage plasticity, even undergoing fundamental lineage reprogramming. This shift in functional potential may suggest a new direction for HIV vaccine design.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

S. F. Lumley et al.

Summary: In a longitudinal study of seropositive and seronegative health care workers undergoing asymptomatic and symptomatic SARS-CoV-2 testing, the presence of anti-spike or anti-nucleocapsid IgG antibodies was associated with a substantially reduced risk of SARS-CoV-2 reinfection in the ensuing 6 months.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Infectious Diseases

SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay

Irene Cassaniti et al.

Summary: The study evaluated the SARS-CoV-2 T-cell response in COVID-19 convalescent patients and unexposed individuals, showing that a majority of convalescent patients had a positive response to at least one SARS-CoV-2 antigen, which could last up to 12 months. The findings suggest that the SARS-CoV-2 T-cell response is primarily mediated by CD4 T cells.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Add to Collection

Article Infectious Diseases

Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients

Alessandra Aiello et al.

Summary: The whole-blood platform was used to detect a SARS-CoV-2-specific T cell response, with pool S and MegaPool being the most potent immunogenic stimuli. The assay showed good sensitivity and high specificity, making it a powerful diagnostic tool for clinical laboratories.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Review Microbiology

SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19

Alba Grifoni et al.

Summary: This review summarizes recent studies on SARS-CoV-2 T cell epitopes, highlighting the significant correlation between epitope number and antigen size. It also presents an analysis of 1,400 different reported SARS-CoV-2 epitopes and identifies discrete immunodominant regions of the virus and more prevalently recognized epitopes.

CELL HOST & MICROBE (2021)

Add to Collection

Review Immunology

SARS-CoV-2-specific T cells in infection and vaccination

Antonio Bertoletti et al.

Summary: Virus-specific T cells during SARS-CoV-2 infection can play a dual role in either protection or pathogenesis, highlighting the importance of studying the function of these cells for future therapeutic and preventative strategies.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Add to Collection

Article Immunology

Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination

Mark M. Painter et al.

Summary: The study found that after SARS-CoV-2 mRNA vaccination, CD4(+) T cell responses in naïve individuals were fast, while CD8(+) T cell responses developed gradually. Th1 and Tfh cell responses after the first dose were correlated with post-boost CD8(+) T cells and neutralizing antibodies.

IMMUNITY (2021)

Add to Collection

Article Immunology

Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants

Saya Moriyama et al.

Summary: Antibody titers against SARS-CoV-2 decrease over time, but the neutralizing potency against the original virus and variants actually improves with time. Late convalescent antibodies show increased neutralization potency against variants, suggesting that antibody response maturation enhances cross-neutralizing ability against circulating variants. This indicates that declining antibody titers may not necessarily mean declining protection.

IMMUNITY (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells

Jae Hyung Jung et al.

Summary: The study reveals that memory T cell responses can be detected in convalescent COVID-19 patients up to 317 days post-symptom onset, indicating potential long-lasting immunity, especially with the presence of stem cell-like memory T cells.

NATURE COMMUNICATIONS (2021)

Add to Collection

Letter Medicine, General & Internal

Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy

Jose Vitale et al.

Summary: This cohort study investigates the rate of SARS-CoV-2 reinfection among individuals in Lombardy, Italy, who had previously recovered from COVID-19.

JAMA INTERNAL MEDICINE (2021)

Add to Collection

Article Cell Biology

Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals

Alison Tarke et al.

Summary: The study showed that SARS-CoV-2 variants do not significantly disrupt total T cell reactivity, although decreases in response frequency of 10%-22% were observed under certain assay/VOC combinations. This underscores the importance of actively monitoring T cell responses in the context of SARS-CoV-2 evolution.

CELL REPORTS MEDICINE (2021)

Add to Collection

Article Infectious Diseases

Clinical immunity in discharged medical patients with COVID-19

Nicola Mumoli et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Add to Collection

Article Immunology

Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome

Daniela Weiskopf et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Carolyn Rydyznski Moderbacher et al.

CELL (2020)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

Nina Le Bert et al.

NATURE (2020)

Add to Collection

Article Rheumatology

Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?

Gaetano Zizzo et al.

LANCET RHEUMATOLOGY (2020)

Add to Collection

Article Immunology

Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers

Gaetano Zizzo et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2019)

Add to Collection

Article Immunology

Activation-induced Markers Detect Vaccine-Specific CD4+ T Cell Responses Not Measured by Assays Conventionally Used in Clinical Trials

Georgina Bowyer et al.

VACCINES (2018)

Add to Collection

Article Immunology

CD137 is a Useful Marker for Identifying CD4+ T Cell Responses to Mycobacterium tuberculosis

Z-H Yan et al.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2017)

Add to Collection

Article Multidisciplinary Sciences

Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells

Samantha Reiss et al.

PLOS ONE (2017)

Add to Collection

Editorial Material Immunology

Class II-Restricted CD8s: New Lessons Violate Old Paradigms

Stephen A. Migueles et al.

IMMUNITY (2016)

Add to Collection

Article Immunology

A Cytokine-Independent Approach To Identify Antigen-Specific Human Germinal Center T Follicular Helper Cells and Rare Antigen-Specific CD4+ T Cells in Blood

Jennifer M. Dan et al.

JOURNAL OF IMMUNOLOGY (2016)

Add to Collection

Article Critical Care Medicine

Combinatorial lmmunoprofiling in Latent Tuberculosis Infection Toward Better Risk Stratification

Patricia Escalante et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Add to Collection

Article Cardiac & Cardiovascular Systems

High Levels of Costimulatory Receptors OX40 and 4-1BB Characterize CD4+CD28null T Cells in Patients With Acute Coronary Syndrome

Ingrid E. Dumitriu et al.

CIRCULATION RESEARCH (2012)

Add to Collection

Article Immunology

Role of increased CD8/CD28null T cells and alternative co-stimulatory molecules in chronic obstructive pulmonary disease

G. Hodge et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)

Add to Collection

Article Multidisciplinary Sciences

A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota

Yingzi Cong et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.